scholarly journals Effects of mometasone furoate/formoterol fumarate fixed-dose combination formulation on chronic obstructive pulmonary disease (COPD): results from a 52-week Phase III trial in subjects with moderate-to-very severe COPD

Author(s):  
Dennis Doherty ◽  
Donald Tashkin ◽  
Kerwin ◽  
Knorr ◽  
Shekar ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document